These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 26131267
1. Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis. Kong F, Wu J, Hu L, Du Y, Pan Y. Int J Clin Exp Med; 2015; 8(4):6412-9. PubMed ID: 26131267 [Abstract] [Full Text] [Related]
2. Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies. Zhao M, Chen P, Dong Y, Zhu X, Zhang X. PLoS One; 2014; 9(1):e87259. PubMed ID: 24475258 [Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals. Leng WD, He MN, Chen QL, Gong H, Zhang L, Zeng XT. Mol Biol Rep; 2013 Oct; 40(10):5987-92. PubMed ID: 24057180 [Abstract] [Full Text] [Related]
6. Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis. Niu YM, Du XY, Lu MY, Xu QL, Luo J, Shen M. Sci Rep; 2015 Aug 17; 5():12972. PubMed ID: 26277865 [Abstract] [Full Text] [Related]
9. Genetic Association between ERCC2, NBN, RAD51 Gene Variants and Osteosarcoma Risk: a Systematic Review and Meta-Analysis. Mehdinejad M, Sobhan MR, Mazaheri M, Zare Shehneh M, Neamatzadeh H, Kalantar SM. Asian Pac J Cancer Prev; 2017 May 01; 18(5):1315-1321. PubMed ID: 28610420 [Abstract] [Full Text] [Related]
10. Association between TGF-β1 Polymorphisms and Head and Neck Cancer Risk: A Meta-Analysis. Shi Q, Wang X, Cai C, Yang S, Huo N, Liu H. Front Genet; 2017 May 01; 8():169. PubMed ID: 29163637 [Abstract] [Full Text] [Related]
11. HOGG1 Ser326Cys polymorphism and susceptibility to head and neck cancer: a meta-analysis. Liu J, Cao XL, Zhang Z, Lei DP, Jin T, Yu XM, Pan XL. Asian Pac J Cancer Prev; 2011 May 01; 12(10):2491-4. PubMed ID: 22320944 [Abstract] [Full Text] [Related]
12. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies. Liu C, Yin Q, Jiao G, Zhou X, Ying M, Gao W, Hu J, Wei L, Wang N, Wang Y. DNA Cell Biol; 2014 Jun 01; 33(6):378-87. PubMed ID: 24694255 [Abstract] [Full Text] [Related]
13. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women. Malisic EJ, Krivokuca AM, Boljevic IZ, Jankovic RN. Cancer Biomark; 2015 Jun 01; 15(5):685-91. PubMed ID: 26406958 [Abstract] [Full Text] [Related]
17. Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis. Han X, Zheng L, Mu YY, Li HZ, He XF. Front Genet; 2022 Jun 01; 13():1032110. PubMed ID: 36437941 [Abstract] [Full Text] [Related]
19. Matrix metalloproteinase-9 -1562C/T promoter polymorphism confers risk for COPD: a meta-analysis. Chen L, Wang T, Liu L, Shen Y, Wan C, Wen F. PLoS One; 2013 Jun 01; 8(3):e60523. PubMed ID: 23555986 [Abstract] [Full Text] [Related]